 Home > Biochemistry News > Biotechnology News > Genxi Biology and Mingji Biology collaborate to develop immune cell therapy for CLDN18.2 positive solid tumors

Genxi Biology and Mingji Biology collaborate to develop immune cell therapy for CLDN18.2 positive solid tumors

 Last Update: 2021-08-27
 Source: Internet
 Author: User

Tags

heart cancer

mitch grassi cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 16, Genxi Biotech announced that it has formally signed an exclusive license agreement with Mingji Biotech.

In this cooperation, Genxi Biologics aims to make full use of its own deep accumulation in the field of immune cell therapy, combined with Mingji Biologics' differentiated fully human CLDN18.

CLDN18.

According to the terms of the agreement, Mingji Bio will receive an advance payment and be entitled to milestone payments based on non-clinical verification, clinical development and commercialization results, as well as low-single-digit royalties

Note: The original text has been deleted

Reference

[1] Clinical Implications of Claudin 18.

[2] Hsu A, Chudasama R, Almhanna K, Raufi A.

[3] The full-length Claudin 18.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.